IE45198B1 - Guanidine derivatives - Google Patents

Guanidine derivatives

Info

Publication number
IE45198B1
IE45198B1 IE1011/77A IE101177A IE45198B1 IE 45198 B1 IE45198 B1 IE 45198B1 IE 1011/77 A IE1011/77 A IE 1011/77A IE 101177 A IE101177 A IE 101177A IE 45198 B1 IE45198 B1 IE 45198B1
Authority
IE
Ireland
Prior art keywords
hydrogen
compound
lower alkyl
pharmaceutically acceptable
general formula
Prior art date
Application number
IE1011/77A
Other languages
English (en)
Other versions
IE45198L (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB23331/76A external-priority patent/GB1530675A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of IE45198L publication Critical patent/IE45198L/xx
Publication of IE45198B1 publication Critical patent/IE45198B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IE1011/77A 1976-06-05 1977-05-17 Guanidine derivatives IE45198B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23331/76A GB1530675A (en) 1976-06-05 1976-06-05 Guanidine derivatives
GB305677 1977-01-26

Publications (2)

Publication Number Publication Date
IE45198L IE45198L (en) 1977-12-05
IE45198B1 true IE45198B1 (en) 1982-07-14

Family

ID=26237989

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1011/77A IE45198B1 (en) 1976-06-05 1977-05-17 Guanidine derivatives

Country Status (15)

Country Link
US (1) US4140793A (OSRAM)
JP (1) JPS52151161A (OSRAM)
AU (1) AU509883B2 (OSRAM)
CA (1) CA1070691A (OSRAM)
CH (1) CH641159A5 (OSRAM)
CY (1) CY1130A (OSRAM)
DE (1) DE2724989A1 (OSRAM)
DK (1) DK248177A (OSRAM)
FR (1) FR2353530A1 (OSRAM)
HK (1) HK57981A (OSRAM)
IE (1) IE45198B1 (OSRAM)
KE (1) KE3170A (OSRAM)
MY (1) MY8200180A (OSRAM)
NL (1) NL7706173A (OSRAM)
SE (1) SE424861B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
GB1588096A (en) * 1978-05-20 1981-04-15 Wyeth & Bros Ltd John Pyrrole derivatives
US4332822A (en) * 1980-02-05 1982-06-01 John Wyeth & Brother Limited Guanidine derivatives
FR2490026A1 (fr) * 1980-09-09 1982-03-12 Thomson Csf Antenne reseau non dispersive et son application a la realisation d'une antenne a balayage electronique
US4563475A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Guanidine derivatives for treating gastrointestinal motility dysfunction
JPH01106831U (OSRAM) * 1988-01-08 1989-07-19
RU2006142552A (ru) * 2004-06-16 2008-07-27 Вайет (Us) Производные амино-5,5-дифенилимидазолона как ингибиторы b-секретазы
PE20060299A1 (es) * 2004-06-16 2006-05-18 Wyeth Corp DIFENILIMIDAZOPIRIMIDINA E -IMIDAZOL AMINAS COMO INHIBIDORES DE ß-SECRETASA
CA2593515A1 (en) * 2005-01-14 2006-07-20 Wyeth Amino-imidazolones for the inhibition of beta-secretase
AU2006211159A1 (en) * 2005-02-01 2006-08-10 Wyeth Amino-pyridines as inhibitors of beta-secretase
JP2008530103A (ja) * 2005-02-14 2008-08-07 ワイス β−セクレターゼ阻害剤としてのアゾリルアシルグアニジン
TW200738683A (en) * 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
WO2007005404A1 (en) * 2005-06-30 2007-01-11 Wyeth AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
TW200730523A (en) * 2005-07-29 2007-08-16 Wyeth Corp Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
CA2623245A1 (en) * 2005-09-26 2007-04-05 Wyeth Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
BRPI0620025A2 (pt) * 2005-12-19 2011-10-25 Wyeth Corp composto, método para o tratamento de uma doença ou transtorno associado a atividade excessiva de bace, método para modular a atividade de bace, composição farmacêutica e uso do composto
WO2007100536A1 (en) * 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) * 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
MX2009003102A (es) * 2006-09-21 2009-04-01 Wyeth Corp INDOLILALQUILPIRIDIN-2-AMINAS PARA LA INHIBICION DE ß-SECRETASA.
PE20090160A1 (es) * 2007-03-20 2009-02-11 Wyeth Corp COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3189601A (en) * 1964-01-10 1965-06-15 Ciba Geigy Corp N, n-alkylene-imino-lower alkanoamidine compounds

Also Published As

Publication number Publication date
CY1130A (en) 1982-02-19
AU509883B2 (en) 1980-05-29
KE3170A (en) 1981-12-18
NL7706173A (nl) 1977-12-07
SE7706520L (sv) 1978-01-20
JPS613332B2 (OSRAM) 1986-01-31
FR2353530B1 (OSRAM) 1981-07-17
DK248177A (da) 1977-12-06
IE45198L (en) 1977-12-05
CH641159A5 (de) 1984-02-15
CA1070691A (en) 1980-01-29
AU2535677A (en) 1978-11-23
DE2724989A1 (de) 1977-12-15
US4140793A (en) 1979-02-20
FR2353530A1 (fr) 1977-12-30
HK57981A (en) 1981-12-04
SE424861B (sv) 1982-08-16
JPS52151161A (en) 1977-12-15
MY8200180A (en) 1982-12-31

Similar Documents

Publication Publication Date Title
IE45198B1 (en) Guanidine derivatives
CA1138451A (en) 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
DK154022B (da) Fremgangsmaade til fremstilling af benzothiazepinderivater
RU2193554C2 (ru) Производные ароматических аминов, обладающих подавляющим оас действием, способ их получения и ингибитор ноас
IL33292A (en) Amino and imino derivatives of thiazolines,thiazolidines and thiazines,their preparation and pharmaceutical compositions containing them
US4017539A (en) Biguanide compounds and anti-diabetic compositions
CA1098909A (en) Indolyloxy-aminopropanol derivatives
CA1088550A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine
IE44316B1 (en) Indazole derivatives
HU186539B (en) Process for producing 1-bracket-1-cyclohexenyl-methyl-bracket closed-2-bracket-2-chloroethyl-bracket closed-pyrrolidine
NZ204893A (en) Benzothiopyranopyridinones and pharmaceutical compositions containing such
US3030378A (en) Five-membered nu-heterocyclic guanidines
US4221798A (en) Hypotensive 2-heterocycloamino-imidazolines
CA1140126A (en) 4-substituted 2-iminoimidazolidine compounds
AU609758B2 (en) Benzamide derivatives
CA1090804A (en) 5,6-dihydro-8,9-dimethoxy-1-methyl-3-(phenylamino) imidazo[5,1-a]isoquinoline compounds
CA1145760A (en) Benzylidene derivatives, their preparation and compositions containing them
US3211789A (en) Aralkylaminoalkylene guanidines
CA1062256A (en) Benzazepine derivatives
US3433802A (en) 3-(n-lower-alkylanilino)pyrrolidines
US4278685A (en) Amide derivatives
CA2005547C (en) Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones
HU204795B (en) Process for producing calcium antagonist cyclic quanidine derivatives and pharmaceutical compositions comprising same
US4161532A (en) N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl) benzamide compounds and derivatives, method of preparation and pharmaceutical preparations
US3922282A (en) 2-Aryl-2-imidazoline-1-propionic acids and their esters